stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Exagen IncXGN
$4.136.35%-0.28
Pre-market: 4.130.00 0.00%

Exagen Inc (XGN)

Exagen Inc stock is traded at $4.13, with a volume of 3,356,988. It is down -6.35% in the last 24 hours and down -46.50% over the past month. Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.
Previous Close:
$4.41
Open:
$4.37
24h Volume:
3,356,988
Relative Volume:
3.08
Market Cap:
$105.37M
Revenue:
$68.38M
Net Income/Loss:
-$20.17M
P/E Ratio:
-
EPS:
-$0.8839
Net Cash Flow:
-$14.13M
1W Performance:
-41.83%
1M Performance:
-46.50%
6M Performance:
+13.46%
1Y Performance:
-54.16%
1-Day Range:
$3.85$4.38
1-Week Range:
$3.85$6.30
52-Week Range:
$2.59$9.74

Exagen Inc Stock (XGN) Company Profile

Name
Exagen Inc
Phone
(760) 560-1501
Address
1261 LIBERTY WAY, VISTA, CA, USA
Employee
216
Next Earnings Date
-
Latest SEC Filings
SEC
XGN's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Exagen Inc Stock (XGN) Financials Data

Similar to XGN